[Creatine phosphokinase, myocardial infarction and intramuscular injection].
D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood*; D003975:Diazepam / Q000008:administration & dosage / Q000627:therapeutic use; D004077:Digoxin / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy*; D010423:Pentazocine / Q000008:administration & dosage / Q000627:therapeutic use
D004077:Digoxin; D008012:Lidocaine; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D003402:Creatine Kinase; D003975:Diazepam; D010423:Pentazocine
Creatine-fosfokinase, hartinfarct en intramusculaire injectie